BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The recommendations were based on level of evidence, efficacy (meta-analysis of the outcomes pain, sleep, fatigue and health-related quality of life), acceptability (total dropout rate), risks (adverse events) and applicability of treatment modalities in the German health care system. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Cognitive behavioral therapy combined with aerobic exercise (multicomponent therapy) is strongly recommended. Relaxation as single therapy should not be applied. The English full-text version of this article is available at SpringerLink (under "Supplemental").
BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The recommendations were based on level of evidence, efficacy (meta-analysis of the outcomes pain, sleep, fatigue and health-related quality of life), acceptability (total dropout rate), risks (adverse events) and applicability of treatment modalities in the German health care system. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: Cognitive behavioral therapy combined with aerobic exercise (multicomponent therapy) is strongly recommended. Relaxation as single therapy should not be applied. The English full-text version of this article is available at SpringerLink (under "Supplemental").
Authors: Dennis C Ang; Rafael Chakr; Steve Mazzuca; Christopher R France; Jennifer Steiner; Timothy Stump Journal: Arthritis Care Res (Hoboken) Date: 2010-05 Impact factor: 4.794
Authors: Saskia van Koulil; Wim van Lankveld; Floris W Kraaimaat; Toon van Helmond; Annemieke Vedder; Hanneke van Hoorn; Rogier Donders; Alphons J L de Jong; Joost F Haverman; Kurt-Jan Korff; Piet L C M van Riel; Hans A Cats; Andrea W M Evers Journal: Arthritis Care Res (Hoboken) Date: 2010-10 Impact factor: 4.794
Authors: G Ferraccioli; L Ghirelli; F Scita; M Nolli; M Mozzani; S Fontana; M Scorsonelli; A Tridenti; C De Risio Journal: J Rheumatol Date: 1987-08 Impact factor: 4.666
Authors: Irene Lund; Thomas Lundeberg; Joakim Carleson; Helene Sönnerfors; Björn Uhrlin; Elisabeth Svensson Journal: Neurosci Lett Date: 2006-05-22 Impact factor: 3.046
Authors: V Köllner; K Bernardy; W Greiner; L Krumbein; H Lucius; M Offenbächer; M Sarholz; M Settan; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: Winfried Häuser; Eva-Maria Hoffmann; Frederick Wolfe; Angus B Worthing; Neil Stahl; Russell Rothenberg; Brian Walitt Journal: Clin Exp Rheumatol Date: 2015-03-18 Impact factor: 4.473
Authors: B Arnold; A Böger; T Brinkschmidt; H-R Casser; D Irnich; U Kaiser; K Klimczyk; J Lutz; M Pfingsten; R Sabatowski; M Schiltenwolf; W Söllner Journal: Schmerz Date: 2018-02 Impact factor: 1.107
Authors: A Galek; B Erbslöh-Möller; V Köllner; H Kühn-Becker; J Langhorst; F Petermann; U Prothmann; A Winkelmann; W Häuser Journal: Schmerz Date: 2013-06 Impact factor: 1.107